CA Patent

CA2673974C — Composition and methods for modulating a kinase cascade

Assigned to Atnx Spv LLC United States · Expires 2017-01-17 · 9y expired

What this patent protects

The invention relates to compositions of N-benzyl-2-(5-(4-(2- morpholinoethoxy)phenyl)pyridin-2-yl)acetamide (KX2-391) and methods for modulating one or more components of a kinase cascade.

USPTO Abstract

The invention relates to compositions of N-benzyl-2-(5-(4-(2- morpholinoethoxy)phenyl)pyridin-2-yl)acetamide (KX2-391) and methods for modulating one or more components of a kinase cascade.

Drugs covered by this patent

Patent Metadata

Patent number
CA2673974C
Jurisdiction
CA
Classification
—
Expires
2017-01-17
Drug substance claim
No
Drug product claim
No
Assignee
Atnx Spv LLC United States
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.